ASTH

Astrana Health Inc

ASTH.US astranahealth.com
38.03
-0.03 (-0.08%)
USD · NASDAQ
52-week range
18.08
51.60
Trading at 60% of the 52-week range
Market Cap
1.89B
P/E Ratio
46.41
Forward P/E
23.04
Book Value
16.87
Div. Yield
N/A
% Institutions
66.15%
% Insiders
22.83%

1 Year

+30.7%

3 Year

+14.5%

10 Year

+827.6%
Description

Astrana Health, Inc., a healthcare management company, provides medical care services in the United States. The company operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company offers care coordination services to patients, families, primary care physicians, specialists, acute care hospitals, alternative sites of inpatient care, physician groups, and health plans. Its physician network includes primary care physicians, specialist physicians and extenders, and hospitalists. The company serves patients primarily covered by private or public insurance, such as Medicare, Medicaid, and health maintenance organization; and non-insured patients. The company was formerly known as Apollo Medical Holdings, Inc. and changed its name to Astrana Health, Inc. in February 2024. Astrana Health, Inc. was founded in 1992 and is headquartered in Alhambra, California.

Company Information

Company Name
Astrana Health Inc
Sector
Healthcare
Industry
Medical Care Facilities
Exchange
NASDAQ
ISIN: US03763A2078
CIK: 0001083446
CUSIP: 03763A108
Currency: USD
Full Time Employees: 3,000
Phone: 626 282 0288
Fiscal Year End: December
IPO Date: Jan 13, 2000
Description:

Astrana Health, Inc., a healthcare management company, provides medical care services in the United States. The company operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company offers care coordination services to patients, families, primary care physicians, specialists, acute care hospitals, alternative sites of inpatient care, physician groups, and health plans. Its physician network includes primary care physicians, specialist physicians and extenders, and hospitalists. The company serves patients primarily covered by private or public insurance, such as Medicare, Medicaid, and health maintenance organization; and non-insured patients. The company was formerly known as Apollo Medical Holdings, Inc. and changed its name to Astrana Health, Inc. in February 2024. Astrana Health, Inc. was founded in 1992 and is headquartered in Alhambra, California.

Address:

1668 S. Garfield Avenue, Alhambra, CA, United States, 91801

People

Directors & Officers

Name Title Year Born
Dr. Kenneth T. Sim F.A.C.S., M.D. Co-Founder & Executive Chairman 1954
Mr. Brandon K. Sim M.S. President & CEO 1994
Dr. Thomas S. Lam M.D., M.P.H. Co-Founder & Vice Chairman 1949
Mr. Chandan Basho M.B.A. CFO, COO & Corporate Secretary 1983
Mr. John Vong CPA, CGMA, M.B.A. Senior VP of Accounting & Principal Accounting Officer 1973
Ms. Rita Pew M.B.A. Chief People Officer NA
Dr. WaiChow Young M.D., M.P.H. Senior Vice President of Health Affairs 1948
Dr. Jeremy R. Jackson M.D. Chief Quality Officer NA
Ms. Jaime Melkonoff M.B.A. President of AstranaCare - Texas NA
Mr. Paul Van Duine M.B.A. Senior Vice President of Contracting NA

Insider Trading

Date Insider Name Title Transaction Type Shares Price Value
Jan 10, 2024 Judy Chu N/A Sale 0.00 $37.66 $0.00
Jan 10, 2024 Judy Chu N/A Purchase 0.00 $37.66 $0.00
Jun 17, 2022 Linda Marsh N/A Sale 250.00K $37.00 $9.25M
Aug 17, 2021 Physicians Of Californi Allied N/A Purchase 40.00K $73.67 $2.95M
Jun 15, 2021 Albert Waichow Young N/A Sale 5.00K $48.58 $242.90K
May 13, 2021 Brandon Sim N/A Purchase 1.00K $31.40 $31.40K
Apr 28, 2021 Physicians Of Californi Allied N/A Purchase 100.00K $24.50 $2.45M
Apr 01, 2021 Physicians Of Californi Allied N/A Sale 1.64M $24.50 $40.13M

Shareholders

Institutional Holders

Holder Name Shares Date Reported % Out Value % Change
BlackRock Inc 6.16M Mar 31, 2026 12.43% $0.00 0.10%
Vanguard Portfolio Management, LLC 2.28M Mar 31, 2026 4.59% $0.00 0.00%
Vanguard Capital Management, LLC 1.71M Mar 31, 2026 3.45% $0.00 0.00%
State Street Corp 1.65M Mar 31, 2026 3.33% $0.00 -1.49%
325 Capital LLC 1.61M Jun 30, 2026 3.25% $17.85 -12.25%
Dimensional Fund Advisors, Inc. 1.47M Jun 30, 2026 2.96% $0.01 7.34%
Wellington Management Company LLP 1.29M Jun 30, 2026 2.61% $0.01 -3.67%
Geode Capital Management, LLC 1.04M Mar 31, 2026 2.09% $0.00 0.96%
683 Capital Management LLC 700.00K Mar 31, 2026 1.41% $0.90 0.00%
Charles Schwab Investment Management Inc 644.17K Mar 31, 2026 1.30% $0.00 17.30%
Bank of America Corp 574.73K Mar 31, 2026 1.16% $0.00 13.34%
Ameriprise Financial Inc 551.60K Mar 31, 2026 1.11% $0.00 25.94%
Hotchkis & Wiley Capital Management LLC 481.52K Mar 31, 2026 0.97% $0.04 15.49%
Diamond Hill Capital Management, LLC 475.94K Jun 30, 2026 0.96% $0.18 -12.52%
Steel Peak Wealth Management LLC 464.94K Jun 30, 2026 0.94% $0.56 -16.97%
Northern Trust Corp 438.16K Mar 31, 2026 0.88% $0.00 8.87%
FMR Inc 416.13K Mar 31, 2026 0.84% $0.00 -61.10%
Royce & Associates, LP 396.96K Mar 31, 2026 0.80% $0.10 13.96%
Jacobs Levy Equity Management, Inc. 386.42K Mar 31, 2026 0.78% $0.04 -18.43%
BNP Paribas Investment Partners SA 351.63K Mar 31, 2026 0.71% $0.01 15.27%

Fund Holdings

Rank Holder Name Shares Held % of Shares Change Date Reported
1 iShares Core S&P Small-Cap ETF 2.59M 5.21% ▲ 0.03% Aug 31, 2026
2 Vanguard MStar Total Stk Mkt Idx Invest 1.42M 2.87% ▲ 0.42% Jul 31, 2026
3 iShares Russell 2000 ETF 1.17M 2.36% ▼ 0.57% Aug 31, 2026
4 Vanguard Small Cap Index 1.02M 2.07% ▲ 0.19% Jul 31, 2026
5 Vanguard MStar Small Cap Growth Indx Inv 591.94K 1.19% ▲ 0.03% Jul 31, 2026
6 Fidelity Small Cap Index 494.53K 1.00% ▲ 21.30% Jun 30, 2026
7 Diamond Hill Small Cap Equity 492.58K 0.99% ▲ 3.50% Jul 31, 2026
8 Vanguard Institutional Extnd Mkt Idx Tr 488.02K 0.98% ▲ 0.17% Jul 31, 2026
9 Diamond Hill Small Cap Inv 430.10K 0.87% ▲ 4.39% Jul 31, 2026
10 iShares Russell 2000 Growth ETF 427.61K 0.86% ▲ 0.00% Aug 31, 2026

Financial Highlights

Market Cap: $1.89B
EBITDA: $174.91M
P/E Ratio: $46.41
PEG Ratio: $0.00
Book Value: $16.87
Earnings/Share: $0.82
Profit Margin: 1.06%
Operating Margin: 3.53%
ROA (TTM): 3.76%
ROE (TTM): 6.90%
Revenue (TTM): $3.84B
Revenue/Share (TTM): $78.21
Earnings Growth (YOY): 110.50%
Revenue Growth (YOY): 48.50%

Valuation Metrics

Enterprise Value: $2.47B
Trailing P/E: 46.41
Forward P/E: 23.04

Shares Statistics

Shares Outstanding: 49.60M
Shares Float: 38.82M
% Insiders: 22.83%
% Institutions: 66.15%
Short % Float: 12.23%

Stock Price History

1 Year Price History

3 Years Price History

10 Years Price History

Financial Charts

Revenue, Net Income & Operating Cash Flow (Yearly)

Revenue, Net Income & Operating Cash Flow (Quarterly)

Operating Expenses (Yearly)

Operating Expenses (Quarterly)

Balance Sheet (Quarterly)

Assets Breakdown (Yearly)

Assets Breakdown (Quarterly)

Liabilities Breakdown (Yearly)

Liabilities Breakdown (Quarterly)

Income Statement Waterfall

Open full waterfall
Line Item
Step Type
Value
Revenue
adjust
$3.18B
Cost of Goods Sold
adjust
$-2.89B
Gross Profit
subtotal
$295.78M
SG&A
adjust
$-217.26M
Operating Income
subtotal
$78.53M
Other / Non-Operating Items
adjust
$-56.04M
Net Income
subtotal
$22.49M

Earnings Per Share (EPS) History

Financial Ratios

📦 Raw API Data (JSON Explorer)

Assistant

×
Hello! I'm your AI assistant. I have access to the financial data on this page. Ask me anything about ASTH.US!